![Thanos Papaïoannou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thanos Papaïoannou
Private Equity Investor at Inertia Ventures
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Andrew Fromkin | M | 58 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
Frank Torti | M | 45 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 years |
Nicolas Jacques-Bouchard | M | - |
Inertia Ventures
![]() Inertia Ventures Investment ManagersFinance Inertia Ventures (Inertia Ventures) is a venture capital firm founded in 2020. The firm is headquartered in New York. | 2 years |
Gillian Cannon | M | 60 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 4 years |
Nikhil Kehtarpal | M | - |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
Richard Pulik | M | - |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
Nish Patel | M | - |
Inertia Ventures
![]() Inertia Ventures Investment ManagersFinance Inertia Ventures (Inertia Ventures) is a venture capital firm founded in 2020. The firm is headquartered in New York. | 4 years |
Zachary Carpenter | M | - |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
Mike Loretz | M | - |
Inertia Ventures
![]() Inertia Ventures Investment ManagersFinance Inertia Ventures (Inertia Ventures) is a venture capital firm founded in 2020. The firm is headquartered in New York. | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Erik Zwicker | M | 44 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Myrtle Potter | F | 65 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 1 years |
Roger Jeffs | M | 62 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 1 years |
Alan Roemer | M | 54 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
Joseph Anthony Piscina | M | 64 |
Ellington Management Group LLC
![]() Ellington Management Group LLC Investment ManagersFinance Ellington Management Group LLC (Ellington) is a SEC-registered investment advisor and hedge fund manager headquartered in Old Greenwich, Connecticut. The firm was founded in 1994 and is primarily owned by Michael Vranos indirectly through his ownership interest in Ellington’s majority owner, EMG Holdings LP. Ellington provides investment advice to pooled investment vehicles and institutional managed accounts. | 3 years |
David S. Moore | M | 50 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 1 years |
Tiago Girão | M | 44 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Darrick Paul Ginkel | M | - |
Ellington Management Group LLC
![]() Ellington Management Group LLC Investment ManagersFinance Ellington Management Group LLC (Ellington) is a SEC-registered investment advisor and hedge fund manager headquartered in Old Greenwich, Connecticut. The firm was founded in 1994 and is primarily owned by Michael Vranos indirectly through his ownership interest in Ellington’s majority owner, EMG Holdings LP. Ellington provides investment advice to pooled investment vehicles and institutional managed accounts. | 3 years |
William T. Symonds | M | 56 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Ashwin Rastogi | M | - |
Ellington Management Group LLC
![]() Ellington Management Group LLC Investment ManagersFinance Ellington Management Group LLC (Ellington) is a SEC-registered investment advisor and hedge fund manager headquartered in Old Greenwich, Connecticut. The firm was founded in 1994 and is primarily owned by Michael Vranos indirectly through his ownership interest in Ellington’s majority owner, EMG Holdings LP. Ellington provides investment advice to pooled investment vehicles and institutional managed accounts. | 2 years |
Salomon Azoulay | M | - |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 1 years |
Karen Segal | M | - |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 1 years |
Alexander Nguyen | M | 47 |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 years |
S Faris AbiNader | M | - |
Ellington Management Group LLC
![]() Ellington Management Group LLC Investment ManagersFinance Ellington Management Group LLC (Ellington) is a SEC-registered investment advisor and hedge fund manager headquartered in Old Greenwich, Connecticut. The firm was founded in 1994 and is primarily owned by Michael Vranos indirectly through his ownership interest in Ellington’s majority owner, EMG Holdings LP. Ellington provides investment advice to pooled investment vehicles and institutional managed accounts. | 5 years |
Matthew Blischak | M | - |
Roivant Sciences, Inc.
![]() Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 24 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thanos Papaïoannou
- Personal Network